Amarin Corp Plc (AMRN)

[ziploc_1]

PWO has never explained why he didn't support Marjac and EPADI in their appeal case base on the fraud that Hikma had used to win their decision at the ninth circuit.

Supporting that case would have been at little or no cost to Amarin ...PWO placed his desire to avoid embarrassing Kennedy and Covington ahead of the interests of Amarin's shareholders...after these attorneys exhibited legal malpractice in not detecting the fraud and calling the court's attention to the fraud.

Judge Du, who was uniformed of the fraud during the case, cited the fraudulently cropped document from the Mori study in her decision to invalidate Amarin's high trig patent for Vascepa...thus opening the way for generics to continuously infringe on Amarin's patent for patent to treat CVDs...as they do to this day.